United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $4.86, $0.32 better than the analyst estimate of $4.54. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $512.69 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.